Screener
Alaunos Therapeutics TCRT Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS-$0.55Beat by $4.35
EPS estimate-$4.90
Next report
Nov 17, 2026 (in 2 months)EPS estimate-$15.75
Versus estimates
Diluted EPS
Q2 2026-$0.41Q1 2026-$0.59Q4 2025-$0.40Beat by $3.29
Q3 2025-$0.55Beat by $4.35
Q2 2025-$0.63Beat by $4.70Q1 2025-$0.67Beat by $5.77FAQ
- When did Alaunos Therapeutics report Q3 2025 earnings?
- Alaunos Therapeutics (TCRT) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were Alaunos Therapeutics's Q3 2025 revenue and EPS?
- Alaunos Therapeutics reported eps of $-0.55 for Q3 2025.
- Did Alaunos Therapeutics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-4.90 by $4.35.
- How did Alaunos Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 21.4% from $-0.70.
- Where can I find Alaunos Therapeutics's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-282988) directly on SEC EDGAR. The filing index links above go to sec.gov.
